The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Immunization without needles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Self-citationRoy, K., Mao, H.-Q., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C., & Steffen, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030595 · Cited by 916
Immune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
NALT- versus PEYER'S-patch-mediated mucosal immunity
Kiyono, H., & Fukuyama, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1439 · Cited by 745
Lipid vesicles and other colloids as drug carriers on the skin
Cevc, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.028 · Cited by 700
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
Oral Immunization with a Recombinant Bacterial Antigen Produced in Transgenic Plants
Haq, T. A., Mason, H. S., Clements, J. D., & Arntzen, C. J. (1995) · Science · doi:10.1126/science.7732379 · Cited by 622
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
Tacket, C. O., Mason, H. S., Losonsky, G., Clements, J. D., Levine, M. M., & Arntzen, C. J. (1998) · Nature Medicine · doi:10.1038/nm0598-607 · Cited by 581
Skin electroporation for transdermal and topical delivery
Denet, A.-R., Vanbever, R., & Préat, V. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.027 · Cited by 531
The vagina as a route for systemic drug delivery
Hussain, A., & Ahsan, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.034 · Cited by 435
Dose Sparing with Intradermal Injection of Influenza Vaccine
Kenney, R. T., Frech, S. A., Muenz, L. R., Villar, C. P., & Glenn, G. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043540 · Cited by 422
Mitragotri, S., & Kost, J. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.024 · Cited by 401
Self-citationMikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., & Harvey, N. G. (2002) · Nature Medicine · doi:10.1038/nm0402-415 · Cited by 398
Matriano, J. A., Cormier, M., Johnson, J., Young, W. A., Buttery, M., Nyam, K., & Daddona, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1013607400040 · Cited by 373
Kane, A., Lloyd, J., Zaffran, M., et al. (1999) · PubMed · Cited by 368
Roy, M. J., Wu, M. S., Barr, L. J., Fuller, J. T., Tussey, L. G., Speller, S., Culp, J., Burkholder, J. K., Swain, W. F., Dixon, R. M., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00302-9 · Cited by 360
Transcutaneous immunization: A human vaccine delivery strategy using a patch
Glenn, G. M., Taylor, D. N., Li, X., Frankel, S., Montemarano, A., & Alving, C. R. (2000) · Nature Medicine · doi:10.1038/82225 · Cited by 321
FEAR OF INJECTIONS IN YOUNG ADULTS: PREVALENCE AND ASSOCIATIONS
NIR, Y., PAZ, A., SABO, E., & POTASMAN, I. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.341 · Cited by 306
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., Mills, K. H. G., Rappuoli, R., & Del Giudice, G. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00553-3 · Cited by 304
Grand Challenges in Global Health
Varmus, H., Klausner, R., Zerhouni, E., Acharya, T., Daar, A. S., & Singer, P. A. (2003) · Science · doi:10.1126/science.1091769 · Cited by 290
Immunogenicity in humans of an edible vaccine for hepatitis B
Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., Goodwin, P., Arntzen, C. J., & Mason, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409899102 · Cited by 290
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
ALPAR, H., SOMAVARAPU, S., ATUAH, K., & BRAMWELL, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287
Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00162-4 · Cited by 274
Smallpox: The Triumph over the Most Terrible of the Ministers of Death
Barquet, N., & Domingo, P. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_1-199710150-00010 · Cited by 263
Skin immunization made possible by cholera toxin
Glenn, G. M., Rao, M., Matyas, G. R., & Alving, C. R. (1998) · Nature · doi:10.1038/36014 · Cited by 261
Chitosan-based nanoparticles for topical genetic immunization
Cui, Z., & Mumper, R. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00407-2 · Cited by 255
Freytag, L. C., & Clements, J. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.010 · Cited by 252
Nasal delivery systems and their effect on deposition and absorption
Kublik, H., & Vidgren, M. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00067-7 · Cited by 248
Recent Advances in Vaccine Adjuvants
Singh, M., & O'Hagan, D. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016104910582 · Cited by 245
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
Van Kampen, K. R., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D.-T., Marks, D., Elmets, C. A., & Tang, D.-C. C. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.043 · Cited by 220
The cost of unsafe injections.
Miller, M., & Pisani, E. (1999) · PubMed · Cited by 215
Kermode, M. (2004) · Health Promotion International · doi:10.1093/heapro/dah110 · Cited by 212
Tezel, A., & Mitragotri, S. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74770-5 · Cited by 210
Self-citationVaccine Policy Changes and Epidemiology of Poliomyelitis in the United States
Alexander, L. N. (2004) · JAMA · doi:10.1001/jama.292.14.1696 · Cited by 203
Belyakov, I. M., Hammond, S. A., Ahlers, J. D., Glenn, G. M., & Berzofsky, J. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420261 · Cited by 203
Hussain, A. A. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00060-4 · Cited by 197
Centers for Disease Control and Prevention
(2013) · Encyclopedia of Behavioral Medicine · doi:10.1007/978-1-4419-1005-9_100268 · Cited by 195
Tacket, C. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00094-8 · Cited by 194
A single-step immunization by sustained antigen release
Preis, I., & Langer, R. S. (1979) · Journal of Immunological Methods · doi:10.1016/0022-1759(79)90341-7 · Cited by 193
New generation of mucosal adjuvants for the induction of protective immunity
Yuki, Y., & Kiyono, H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.398 · Cited by 191
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Chen, H., Torchilin, V., & Langer, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030202104 · Cited by 186
Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power
Schramm-Baxter, J., & Mitragotri, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.006 · Cited by 183
Self-citationImmunization via hair follicles by topical application of naked DNA to normal skin
Fan, H., Lin, Q., Morrissey, G. R., & Khavari, P. A. (1999) · Nature Biotechnology · doi:10.1038/12856 · Cited by 182
Oral particulate delivery: status and future trends
Chen, H. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00047-7 · Cited by 181
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
Kim, T. W., Hung, C., Ling, M. F., Juang, J., He, L., Hardwick, J. M., Kumar, S., & Wu, T. ‐. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17293 · Cited by 179
New advances in microsphere-based single-dose vaccines
Hanes, J., Cleland, J. L., & Langer, R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00053-7 · Cited by 176
Stoitzner, P., Holzmann, S., McLellan, A. D., Ivarsson, L., Stössel, H., Kapp, M., Kämmerer, U., Douillard, P., Kämpgen, E., Koch, F., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12042.x · Cited by 170
Challacombe, S., Rahman, D., Jeffery, H., Davis, S. S., & O’Hagan, D. T. (1992) · PubMed Central · Cited by 164
Can needle-free administration of vaccines become the norm in global immunization?
Levine, M. M. (2003) · Nature Medicine · doi:10.1038/nm0103-99 · Cited by 158
Kersten, G. F. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00540-6 · Cited by 156
New Aspects of the Skin Barrier Organization
Bouwstra, J. A., Pilgram, G. S. K., Gooris, G. S., Koerten, H. K., & Ponec, M. (2001) · Skin Pharmacology and Physiology · doi:10.1159/000056391 · Cited by 148
Centers for Disease Control and Prevention
(2004) · Sage eBooks · doi:10.4135/9781412952576.n51 · Cited by 142
Transdermal Drug Delivery by Jet Injectors: Energetics of Jet Formation and Penetration
Schramm, J., & Mitragotri, S. (2002) · Pharmaceutical Research · doi:10.1023/a:1020753329492 · Cited by 139
Self-citationLow-frequency ultrasound as a transcutaneous immunization adjuvant
Tezel, A., Paliwal, S., Shen, Z., & Mitragotri, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.02.027 · Cited by 139
Self-citationGlück, U., Gebbers, J., & Glück, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7780-7786.1999 · Cited by 137
Novel Approaches to Vaccine Delivery
O’Hagan, D. T., & Rappuoli, R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041443.17935.33 · Cited by 133
Jackson, L. A., Austin, G., Chen, R. T., Stout, R. R., Destefano, F. R., Gorse, G. J., Newman, F. K., Yu, O., & Weniger, B. G. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00225-0 · Cited by 132
Scharton‐Kersten, T., Yu, J., Vassell, R. A., O’Hagan, D. T., Alving, C. R., & Glenn, G. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.5306-5313.2000 · Cited by 125
Bioengineering of Therapeutic Aerosols
Edwards, D. A., & Dunbar, C. (2002) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.4.100101.132311 · Cited by 125
Recent advances in mucosal vaccines and adjuvants
Eriksson, K., & Holmgren, J. R. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00384-9 · Cited by 124
Bramson, J. L., Dayball, K., Evelegh, C. M., Wan, Y., Page, D. T. P., & Smith, A. M. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301886 · Cited by 118
Parameters affecting the immunogenicity of microencapsulated tetanus toxoid
Esparza, I., & Kissel, T. (1992) · Vaccine · doi:10.1016/0264-410x(92)90094-z · Cited by 118
Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation
Zhang, L., Nolan, E. F., Kreitschitz, S., & Rabussay, D. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00270-2 · Cited by 118
Chew, J. L., Wolfowicz, C. B., Mao, H., Leong, K. W., & Chua, K. Y. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00228-7 · Cited by 115
Needle-free epidermal powder immunization
Chen, D., Maa, Y., & Haynes, J. R. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.3.265 · Cited by 114
Topical immunization using nanoengineered genetic vaccines
Cui, Z., & Mumper, R. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00051-2 · Cited by 114
Microparticles for intranasal immunization
Vajdy, M., & O’Hagan, D. T. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00167-3 · Cited by 114
Tacket, C. O., Reid, R. H., Boedeker, E. C., Losonsky, G. A., Nataro, J. P., Bhagat, H. R., & Edelman, R. (1994) · Vaccine · doi:10.1016/s0264-410x(94)80038-2 · Cited by 114
Archer, D. F., Bigrigg, A., Smallwood, G. H., Shangold, G. A., Creasy, G. W., & Fisher, A. C. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03263-0 · Cited by 111
Katz, D. E., Delorimier, A., Wolf, M. K., Hall, E. R., Cassels, F. J., van Hamont, J. E., Newcomer, R., Davachi, M. A., Taylor, D. N., & McQueen, C. E. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00613-8 · Cited by 109
Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines
Vajdy, M., Srivastava, I. K., Polo, J., Donnelly, J., O’Hagan, D. T., & Singh, M. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01288.x · Cited by 105
Epstein, J. E., Gorak, E. J., Charoenvit, Y., Wang, R., Freydberg, N., Osinowo, O., Richie, T. L., Stoltz, E. L., Trespalacios, F. C., Nerges, J. A., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201644 · Cited by 100
An Outbreak of Hepatitis B Associated With Jet Injections in a Weight Reduction Clinic
Canter, J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390200105020 · Cited by 97
Seo, N., TOKURA, Y., Nishijima, T., Hashizume, H., Furukawa, F., & Takigawa, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.371 · Cited by 95
Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch
Frech, S. A., Kenney, R. T., Spyr, C., Lazar, H., Viret, J., Herzog, C., Glück, R., & Glenn, G. M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.036 · Cited by 92
Raviprakash, K. S., Ewing, D. F., Simmons, M., et al. (2003) · Virology · doi:10.1016/s0042-6822(03)00542-7 · Cited by 91
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus
Smith, D. J., Bot, S., Dellamary, L. A., & Bot, A. I. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00224-x · Cited by 90
Breau, L. M., McGrath, P. J., Craig, K. D., Santor, D. A., Cassidy, K.-L., & Reid, G. J. (2001) · Clinical Journal of Pain · doi:10.1097/00002508-200106000-00011 · Cited by 84
Kersten, G. F. A., & Hirschberg, H. J. H. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.453 · Cited by 84
Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant
BenMohamed, L., Belkaid, Y., Loing, E., Brahimi, K., Gras‐Masse, H., & Druilhe, P. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2274::aid-immu2274>3.0.co;2-c · Cited by 81
Novel approaches to ocular drug delivery.
Davis, J. L., Gilger, B. C., & Robinson, M. R. (2004) · PubMed · Cited by 79
Induction of Protective Immunity against Lethal Anthrax Challenge with a Patch
Kenney, R. T., Yu, J., Guebre‐Xabier, M., Frech, S. A., Lambert, A. M., Heller, B. A., Ellingsworth, L. R., Eyles, J. E., Williamson, E. D., & Glenn, G. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/422694 · Cited by 79
Microparticle targeting to M cells
Ermak, T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00043-x · Cited by 75
Roberts, L. K., Barr, L. J., FULLER, D. H., McMahon, C. W., Leese, P. T., & Jones, S. W. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.05.026 · Cited by 74
Ekwueme, D. U., Weniger, B. G., & Chen, R. T. (2002) · Europe PMC (PubMed Central) · Cited by 73
Oral vaccination in man using antigens in particles: current status
Brayden, D. J. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00175-0 · Cited by 72
Kendall, M. A. F., Rishworth, S., Carter, F., & Mitchell, T. J. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22320.x · Cited by 69
Intradermal DNA immunization by using jet-injectors in mice and monkeys
Haensler, J., Verdelet, C., Sanchez, V., Girerd-Chambaz, Y., Bonnin, A., Trannoy, E., Krishnan, S., & Meulien, P. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00242-4 · Cited by 66
Wikingsson, L. D. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00288-8 · Cited by 64
Evaluation of a needle‐free injection system for local anaesthesia prior to venous cannulation
Cooper, J. A., Bromley, L. M., Baranowski, A. P., & Barker, S. G. E. (2000) · Anaesthesia · doi:10.1046/j.1365-2044.2000.01210.x · Cited by 61
Lambert, J. S., Keefer, M. C., Mulligan, M. J., Schwartz, D. H., Mestecky, J., Weinhold, K. J., Smith, C. S., Hsieh, R., Moldoveanu, Z., Fast, P., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00051-2 · Cited by 51
Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.
(2004) · PubMed · Cited by 47
The role of particle-mediated DNA vaccines in biodefense preparedness
Dean, H. J., Haynes, J. R., & Schmaljohn, C. S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.012 · Cited by 46
Targeting approaches to oral drug delivery
Lambkin, I., & Pinilla, C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.67 · Cited by 44
Low-volume jet injection for intradermal immunization in rabbits
Ren, S. V., Li, M., Smith, J. M., DeTolla, L. J., & Furth, P. A. (2002) · BMC Biotechnology · doi:10.1186/1472-6750-2-10 · Cited by 44
Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen.
Nellore, R. V., Pande, P. G., Young, D., & Bhagat, H. R. (1992) · PubMed · Cited by 42
Bödey, B., Bödey, B., & Kaiser, H. E. (1997) · PubMed · Cited by 38
Development of oral vaccines for human use.
Ar, F. (2000) · PubMed · Cited by 37
Stertman, L., Strindelius, L., & Sjöholm, I. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.019 · Cited by 36
Kato, H., Bukawa, H., Hagiwara, E., Xin, K.-Q., Hamajima, K., Kawamoto, S., Sugiyama, M., Sugiyama, M., Noda, E., Nishizaki, M., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00385-0 · Cited by 36
Hamajima, K., Hoshino, Y., Xin, K.-Q., Hayashi, F., Tadokoro, K., & Okuda, K. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5141 · Cited by 35
O’Hagan, D. T., & Rappuoli, R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03234-9 · Cited by 31
Immunization for Protection of the Reproductive Tract: A Review
Russell, M. W. (2002) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2002.01099.x · Cited by 27
PELA microspheres loadedH. pylorilysates and their mucosal immune response
Ren, J.-M. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i6.1098 · Cited by 26
Takigawa, M., TOKURA, Y., Hashizume, H., Yagi, H., & Seo, N. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03717.x · Cited by 20
Cited by
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Nanoemulsions: Formation, properties and applications
Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016) · Soft Matter · doi:10.1039/c5sm02958a · Cited by 1,633
Alkilani, A., McCrudden, M. T., & Donnelly, R. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7040438 · Cited by 1,147
Dissolving polymer microneedle patches for influenza vaccination
Sullivan, S. P., Koutsonanos, D. G., del Pilar Martin, M., Lee, J. W., Zarnitsyn, V., Choi, S.-O., Murthy, N., Compans, R. W., Skountzou, I., & Prausnitz, M. R. (2010) · Nature Medicine · doi:10.1038/nm.2182 · Cited by 948
Polymer Microneedles for Controlled-Release Drug Delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0028-9 · Cited by 493
Metadata
- Authors
- Mitragotri, S.
- Venue
- Nature Reviews Immunology
- Published
- 2005-10-20
- Volume
- 5
- Issue
- 12
- Pages
- 905-916
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2052818607
- Cited by
- 395
- References
- 110
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.